The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of safety and efficacy of tislelizumab plus chemotherapy in stage II-IV non small cell lung cancer (LungMark).
 
Yaobin Lin
No Relationships to Disclose
 
You-Hao Chen
No Relationships to Disclose
 
Zhi-Chao Lin
No Relationships to Disclose
 
Ming Zhou
No Relationships to Disclose
 
Wen-Yu Zhai
No Relationships to Disclose
 
Ze-Rui Zhao
No Relationships to Disclose
 
Bing-Yu Rao
No Relationships to Disclose
 
Yu-Heng Zhou
No Relationships to Disclose
 
Min Huang
No Relationships to Disclose
 
Hao Long
No Relationships to Disclose